Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 163521 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | SODIUM CHLORIDE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 30 ML |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-07-01 |
Actual start date | 2022-07-01 |
Estimated end date | 2022-08-15 |
Actual end date | 2022-08-15 |
Shortage status | Resolved |
Updated date | 2022-08-21 |
Company comments | We will be extending our backorder on Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL until August 15, 2022. Once available, this product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-21 | French | Compare |
v6 | 2022-08-21 | English | Compare |
v5 | 2022-07-29 | French | Compare |
v4 | 2022-07-29 | English | Compare |
v3 | 2022-07-02 | English | Compare |
v2 | 2022-06-27 | French | Compare |
v1 | 2022-06-27 | English | Compare |
Showing 1 to 7 of 7